Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:DDXSOTCMKTS:EVSPOTCMKTS:MJNEOTCMKTS:USRM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDDXSDiadexus$0.00$0.01▼$5.40$53KN/A15,481 shs30 shsEVSPEnvironmental Service Professionals$0.00$0.00▼$0.00$64KN/A962,153 shsN/AMJNEMJ$0.00+∞$0.00$0.00▼$0.10$17K-0.0858,895 shs200 shsUSRMU.S. Stem Cell$0.00$0.00$0.00▼$0.00$64K-1.45139,765 shs111,616 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDDXSDiadexus0.00%0.00%0.00%0.00%0.00%EVSPEnvironmental Service Professionals0.00%0.00%0.00%0.00%0.00%MJNEMJ0.00%-70.00%+50.00%+200.00%-96.25%USRMU.S. Stem Cell0.00%0.00%-50.00%-50.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDDXSDiadexusN/AN/AN/AN/AN/AN/AN/AN/AEVSPEnvironmental Service ProfessionalsN/AN/AN/AN/AN/AN/AN/AN/AMJNEMJN/AN/AN/AN/AN/AN/AN/AN/AUSRMU.S. Stem CellN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDDXSDiadexus 0.00N/AN/AN/AEVSPEnvironmental Service Professionals 0.00N/AN/AN/AMJNEMJ 0.00N/AN/AN/AUSRMU.S. Stem Cell 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDDXSDiadexusN/AN/AN/AN/AN/AN/AEVSPEnvironmental Service ProfessionalsN/AN/AN/AN/AN/AN/AMJNEMJ$360K0.05N/AN/AN/A∞USRMU.S. Stem Cell$80K0.79N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDDXSDiadexusN/AN/A0.00N/AN/AN/AN/AN/AN/AEVSPEnvironmental Service ProfessionalsN/AN/A0.00N/AN/AN/AN/AN/AN/AMJNEMJ-$5.38MN/A0.00∞N/AN/AN/AN/AN/AUSRMU.S. Stem Cell-$2.86MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDDXSDiadexusN/AN/AN/AN/AN/AEVSPEnvironmental Service ProfessionalsN/AN/AN/AN/AN/AMJNEMJN/AN/AN/AN/AN/AUSRMU.S. Stem CellN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDDXSDiadexusN/AEVSPEnvironmental Service ProfessionalsN/AMJNEMJN/AUSRMU.S. Stem CellN/AInsider OwnershipCompanyInsider OwnershipDDXSDiadexusN/AEVSPEnvironmental Service ProfessionalsN/AMJNEMJ35.92%USRMU.S. Stem Cell16.72%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDDXSDiadexusN/A4.10 millionN/ANot OptionableEVSPEnvironmental Service Professionals9643.75 millionN/ANot OptionableMJNEMJ958.27 million37.34 millionNot OptionableUSRMU.S. Stem Cell11635.53 million550.90 millionNot OptionableMJNE, EVSP, USRM, and DDXS HeadlinesRecent News About These CompaniesHow our bones are repaired by skeletal stem cells: Scientist discover four major subtypesJune 4 at 12:33 PM | msn.comFirst Stem Cell Nerve Therapy Meant to Reverse Paralysis Enters Clinical TrialMay 28, 2025 | msn.comVascularized stem cell islet organoids offer improved model for diabetes researchMay 23, 2025 | msn.comFirst successful allogeneic stem cell transplant using deceased donor in blood cancer clinical trialMay 17, 2025 | sciencex.comStem cells coaxed into most advanced amniotic sacs ever grown in the labMay 15, 2025 | nature.comNewly discovered ‘super stem cells’ can transform into better versions of themselvesMay 7, 2025 | bgr.comUltrasound and microrobots team up to boost stem cell therapy for brain repairApril 30, 2025 | msn.comA dangerous new push to ban embryonic stem cell research funding is gaining momentumApril 30, 2025 | statnews.comFederal Circuit Affirms Stem Cell Product-by-Process Claims: Lessons in Claim Construction and Inherency from Restem LLV v. Jadi Cell LLCApril 25, 2025 | jdsupra.comDespite political pushback, the Yale Stem Cell Center has emerged as a leader in regenerative medicineApril 25, 2025 | yaledailynews.comNew approach targets cell surface protein to treat leukemia and solid tumorsApril 24, 2025 | msn.comDNA organization offers clues for advancing stem cell therapyApril 17, 2025 | news.ucr.eduNeural stem cells outside the brain: Discovery opens new paths for regenerative medicineApril 10, 2025 | msn.comWorld’s first human trial of sperm stem cell therapy aims to reverse male infertilityApril 7, 2025 | msn.comDrug-delivering aptamers target leukemia stem cells for a one-two knockout punchApril 3, 2025 | msn.comSperm Stem Cells Were Used for the First Time in an Attempt to Restore FertilityMarch 28, 2025 | wired.comParalysed man stands again after receiving ‘reprogrammed’ stem cellsMarch 24, 2025 | nature.comScientists create universal vascular graft with stem cells to improve surgery for cardiovascular diseaseMarch 10, 2025 | msn.comFLIpping the switch: DNA regulator activates blood stem cells for improved transplantation successMarch 10, 2025 | msn.comStem Cell Therapy Repairs Cornea Damage Thought IrreversibleMarch 10, 2025 | hms.harvard.eduMedia Sentiment Over TimeMJNE, EVSP, USRM, and DDXS Company DescriptionsDiadexus OTCMKTS:DDXSDiadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.Environmental Service Professionals OTCMKTS:EVSPEnvironmental Service Professionals, Inc., through its subsidiaries, provides environmental consulting services for addressing mold and moisture intrusion and the associated acute or chronic issues that impact the interior air quality of commercial and residential buildings. The company offers Certified Environmental Home Inspector (CEHI) program, a training, certification, inspection, and results reporting analysis program that provides moisture and toxin inspection, as well as energy use awareness to residential and commercial clients. It also provides cross-training on CEHI programs for insurance companies, underwriters, and loss control and risk management personnel. Environmental Service Professionals, Inc. was formerly known as Pacific Environmental Sampling, Inc. and changed its name to Environmental Service Professionals, Inc. in October 2006. The company was incorporated in 1992 and is based in Palm Springs, California.MJ OTCMKTS:MJNE$0.0003 +0.00 (+∞) As of 06/3/2025 09:52 AM EasternMJ Holdings, Inc., a cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada. It is also involved in production of cannabis related products; and provision of management services, dispensaries, and consulting services. The company is headquartered in Las Vegas, Nevada.U.S. Stem Cell OTCMKTS:USRM$0.0001 0.00 (0.00%) As of 06/3/2025 02:50 PM EasternU.S. Stem Cell, Inc., a biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company's lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of acute myocardial infarction, chronic heart ischemia, and lower limb ischemia. Its pipeline products include MyoCell SDF-1, an autologous muscle-derived cellular therapy for enhancing cardiac function in chronic heart failure patients. The company is also developing MyoCath, a deflecting tip needle injection catheter that is used to inject cells into cardiac tissue in therapeutic procedures to treat chronic heart ischemia and congestive heart failure. In addition, it provides physician and patient based regenerative medicine/cell therapy training, cell collection, and cell storage services; and cell collection and treatment kits for humans and animals, as well as operates a cell therapy clinic to provide cellular treatments for patients afflicted with neurological, autoimmune, orthopedic, and degenerative diseases. The company also offers various courses for physicians and other health care professionals. The company was formerly known as Bioheart, Inc. and changed its name to U.S. Stem Cell, Inc. in October 2015. U.S. Stem Cell, Inc. was incorporated in 1999 and is headquartered in Sunrise, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Guidewire Rockets Higher: A Move Above $300 Is Probable TSMC Joins NVIDIA in UAE Push, Fueling Growth Outlook Constellation Energy and Meta Strike Nuclear Deal, Shares Whipsaw Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge Analog Devices' Cyclical Recovery Story Has Just Begun Microsoft Stock Near Peak, Pullback Seen as Opportunity 3 Reasons Amazon Could Be the Best Tech Performer in June 3 Tech Stocks Insiders Are Buying: Speculative Plays for June Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
